Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With Malignant Pleural Effusion: A Retrospective Multicenter Cohort Study

INTRODUCTION: Malignant pleural effusion (MPE) is associated with poor treatment outcome in patients with NSCLC receiving immune checkpoint inhibitors (ICIs). ICIs and chemotherapy (ICI/Chemo) combination therapy is currently the standard therapy for NSCLC, and some ICI/Chemo regimens for nonsquamou...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawachi, Hayato, Tamiya, Motohiro, Taniguchi, Yoshihiko, Yokoyama, Toshihide, Yokoe, Shinya, Oya, Yuko, Imaji, Mihoko, Okabe, Fukuko, Kanazu, Masaki, Sakata, Yoshihiko, Uematsu, Shinya, Tanaka, Satoshi, Arai, Daisuke, Saito, Go, Kobe, Hiroshi, Miyauchi, Eisaku, Okada, Asuka, Hara, Satoshi, Kumagai, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234704/
https://www.ncbi.nlm.nih.gov/pubmed/35769388
http://dx.doi.org/10.1016/j.jtocrr.2022.100355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234704/
https://www.ncbi.nlm.nih.gov/pubmed/35769388
http://dx.doi.org/10.1016/j.jtocrr.2022.100355

Ejemplares similares